Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

BACKGROUND: Ovarian epithelial tumor (OET) is a silent disease of late diagnosis and poor prognosis. Currently treatment options are limited and patient response to treatment is difficult to predict so there is a serious need to delineate the real pathogenesis to predict tumour prognosis. Prohibitin...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Etreby, Nour M., Ghazy, Amany A., Rashad, Radwaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399399/
https://www.ncbi.nlm.nih.gov/pubmed/28427435
http://dx.doi.org/10.1186/s13048-017-0325-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399399/
https://www.ncbi.nlm.nih.gov/pubmed/28427435
http://dx.doi.org/10.1186/s13048-017-0325-4

Ejemplares similares